Recently, USP48 and BRAF have been reported as additional target genes, with somatic variants of BRAF gene in 16% of patients and of USP48 gene in 23% of USP8-negative corticotropinomas [109]. The gene discussed is BRAF; the disease is ACTH-producing pituitary gland adenoma.